These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19434630)

  • 41. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress.
    Sharma M; Coen DM
    J Virol; 2014 Sep; 88(18):10982-5. PubMed ID: 24965476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M; Goyette N; Boivin G
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.
    Reitsma JM; Terhune SS
    Antiviral Res; 2013 Nov; 100(2):321-7. PubMed ID: 24070820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.
    Underwood MR; Harvey RJ; Stanat SC; Hemphill ML; Miller T; Drach JC; Townsend LB; Biron KK
    J Virol; 1998 Jan; 72(1):717-25. PubMed ID: 9420278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment.
    Goldberg MD; Honigman A; Weinstein J; Chou S; Taraboulos A; Rouvinski A; Shinder V; Wolf DG
    J Virol; 2011 Apr; 85(7):3375-84. PubMed ID: 21248036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase.
    Michel D; Pavić I; Zimmermann A; Haupt E; Wunderlich K; Heuschmid M; Mertens T
    J Virol; 1996 Sep; 70(9):6340-6. PubMed ID: 8709262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome.
    Oberstein A; Perlman DH; Shenk T; Terry LJ
    Proteomics; 2015 Jun; 15(12):2006-22. PubMed ID: 25867546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase.
    Baek MC; Krosky PM; Pearson A; Coen DM
    Virology; 2004 Jun; 324(1):184-93. PubMed ID: 15183065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65.
    Kamil JP; Coen DM
    J Virol; 2007 Oct; 81(19):10659-68. PubMed ID: 17634236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
    Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
    J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase.
    Wolf DG; Honigman A; Lazarovits J; Tavor E; Panet A
    Arch Virol; 1998; 143(6):1223-32. PubMed ID: 9687879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.
    Maertens J; Cordonnier C; Jaksch P; Poiré X; Uknis M; Wu J; Wijatyk A; Saliba F; Witzke O; Villano S
    N Engl J Med; 2019 Sep; 381(12):1136-1147. PubMed ID: 31532960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.
    Prichard MN; Gao N; Jairath S; Mulamba G; Krosky P; Coen DM; Parker BO; Pari GS
    J Virol; 1999 Jul; 73(7):5663-70. PubMed ID: 10364316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity.
    Azzeh M; Honigman A; Taraboulos A; Rouvinski A; Wolf DG
    Virology; 2006 Oct; 354(1):69-79. PubMed ID: 16872656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
    Iwahori S; Hakki M; Chou S; Kalejta RF
    J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.
    Reitsma JM; Savaryn JP; Faust K; Sato H; Halligan BD; Terhune SS
    Cell Host Microbe; 2011 Feb; 9(2):103-14. PubMed ID: 21320693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function.
    Hume AJ; Finkel JS; Kamil JP; Coen DM; Culbertson MR; Kalejta RF
    Science; 2008 May; 320(5877):797-9. PubMed ID: 18467589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient.
    Schubert A; Ehlert K; Schuler-Luettmann S; Gentner E; Mertens T; Michel D
    BMC Infect Dis; 2013 Jul; 13():330. PubMed ID: 23870704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.